Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx (LUNG) has 7 years of Gross Margin data on file, last reported at 74.65% in Q3 2025.

• Gross Margin for Q3 2025 came in at 74.65%, up 95.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 73.3% (down 86.0% YoY), and the FY2024 annual result was 74.0%, up 9.0% from the prior year.
• Gross Margin grew to 74.65% in Q3 2025 per LUNG's latest filing, from 72.11% in the prior quarter.
• Over five years, Gross Margin peaked at 75.21% in Q1 2022 and troughed at 71.52% in Q1 2021.
• A 5-year average of 73.79% and a median of 73.99% in 2021 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2021 and 2023: Gross Margin surged 4644 bps in 2021, then tumbled 235 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 74.78% in 2021, then decreased by 3 bps to 72.51% in 2022, then climbed by 3 bps to 74.7% in 2023, then dropped by 1 bps to 74.02% in 2024, then rose by 1 bps to 74.65% in 2025.
• Business Quant data shows LUNG's Gross Margin at 74.65% in Q3 2025, 72.11% in Q2 2025, and 72.51% in Q1 2025.